Oral vaccines and novel tech: CEPI announces grants for ‘variant-proof’ COVID-19 vaccine development

Oral vaccines and novel tech: CEPI announces grants for ‘variant-proof’ COVID-19 vaccine development

Submitted by admin on November 5, 2021 - 12:52pm
Source: 
Biopharma Reporter
News Tags: 
CEPI
vaccines
COVID-19
drug development
funding
COVID-19 variants
Headline: 
Oral vaccines and novel tech: CEPI announces grants for ‘variant-proof’ COVID-19 vaccine development
snippet: 

CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the first funding awards under a $200m program to advance development of vaccines against SARS-CoV-2 variants and other betacoronaviruses.

Do Not Allow Advertisers to Use My Personal information